share_log

康弘药业:北京市通商(深圳)律师事务所关于成都康弘药业集团股份有限公司2021年股票期权激励计划行权价格调整的法律意见书

Chengdu Kanghong Pharmaceutical Group: Legal Opinion of Beijing Commerce (Shenzhen) Law Firm on the adjustment of the exercise price of the 2021 stock option incentive plan of Chengdu Kanghong Pharmaceutical Group Co., Ltd.

SZSI ·  May 27
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more